Skip to main content
Alert:

Is your dog limping? Check out our pet owner website.

Utility Menu

  • Exubrion
    • Board of Directors
    • Leadership
    • Advisory Board
  • Package Insert
  • Licensing Support
  • CE Library
  • FastStart Kit
  • Treatment Centers

Main navigation

  • How It Works
  • Pain of OA
  • Resources
    • Success Stories
    • Effectiveness
    • Resources
  • Contact Us

Utility Menu

  • Exubrion
    • Board of Directors
    • Leadership
    • Advisory Board
  • Package Insert
  • Licensing Support
  • CE Library
  • FastStart Kit
  • Treatment Centers

Technical Information

 

“Canine joint therapy with Synovetin OA™ has early disease-modifying effects by breaking the inflammatory cycle associated with synovitis” Technical Bulletin

“Canine joint therapy with Synovetin OA™ has early disease-modifying effects by breaking the inflammatory cycle associated with synovitis” Technical Bulletin

“Radiosynoviorthesis: A new therapeutic and diagnostic tool for canine joint inflammation” Technical Bulletin

“Radiosynoviorthesis: A new therapeutic and diagnostic tool for canine joint inflammation” Technical Bulletin

“Safety and effectiveness of Synovetin OA™: Results of three randomized trials evaluating treatment of naturally occurring canine elbow osteoarthritis” Technical Bulletin

“Safety and effectiveness of Synovetin OA™: Results of three randomized trials evaluating treatment of naturally occurring canine elbow osteoarthritis” Technical Bulletin

RAM Navigator  Program Brochure

Exubrion Therapeutics Corporate Overview

Synovetin OA™ Product Overview

Synovetin OA™ Product Overview

Inflammatory Cycle

Inflammatory Cycle

Assessment of Canine Elbow Joint for Osteoarthritis

Assessment of Canine Elbow Joint for Osteoarthritis

RAM Navigator

RAM Navigator Program Brochure

Tin-117m Spec Sheet

Tin-117m Spec Sheet

Synovetin OA® delivers sustained OA pain relief.1

Learn about once-yearly treatment

Synovetin OA® provides targeted, non-systemic therapy.2

Review the safety data

References:

  1. Data on file, Exubrion Therapeutics.
  2. Donecker JM, Fox SM. Safety and effectiveness of Synovetin OA™: Results of three randomized trials evaluating treatment of naturally occurring canine elbow osteoarthritis. Exubrion Therapeutics, July 2019.

Synovetin OA® is marketed by:

Exubrion

© 2022 Exubrion Therapeutics, Inc. All rights reserved.
5203 Bristol Industrial Way | Buford, GA 30518
833-942-1247 | info@exubrion.com | Privacy Policy | Terms & Conditions
facbook linkedin